232 related articles for article (PubMed ID: 25817828)
1. Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy.
Ren X; Wu X; Hillier SG; Fegan KS; Critchley HO; Mason JI; Sarvi S; Harlow CR
J Steroid Biochem Mol Biol; 2015 Jun; 150():54-63. PubMed ID: 25817828
[TBL] [Abstract][Full Text] [Related]
2. The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
Hevir-Kene N; Rižner TL
Chem Biol Interact; 2015 Jun; 234():309-19. PubMed ID: 25437045
[TBL] [Abstract][Full Text] [Related]
3. New development in intracrinology of breast carcinoma.
Sasano H; Suzuki T; Nakata T; Moriya T
Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
[TBL] [Abstract][Full Text] [Related]
4. Expression of enzymes involved in synthesis and metabolism of estradiol in human breast as studied by immunocytochemistry and in situ hybridization.
Li Z; Luu-The V; Poisson-Paré D; Ouellet J; Li S; Labrie F; Pelletier G
Histol Histopathol; 2009 Mar; 24(3):273-82. PubMed ID: 19130396
[TBL] [Abstract][Full Text] [Related]
5. Estrogen inhibits cell proliferation through in situ production in human thymoma.
Ishibashi H; Suzuki T; Suzuki S; Moriya T; Kaneko C; Nakata T; Sunamori M; Handa M; Kondo T; Sasano H
Clin Cancer Res; 2005 Sep; 11(18):6495-504. PubMed ID: 16166425
[TBL] [Abstract][Full Text] [Related]
6. Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells.
Jia Y; Domenico J; Swasey C; Wang M; Gelfand EW; Lucas JJ
PLoS One; 2014; 9(5):e97448. PubMed ID: 24848372
[TBL] [Abstract][Full Text] [Related]
7. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral estrogen disposition in breast cancer.
Haynes BP; Straume AH; Geisler J; A'Hern R; Helle H; Smith IE; Lønning PE; Dowsett M
Clin Cancer Res; 2010 Mar; 16(6):1790-801. PubMed ID: 20215536
[TBL] [Abstract][Full Text] [Related]
9. Disturbed estrogen and progesterone action in ovarian endometriosis.
Smuc T; Hevir N; Ribic-Pucelj M; Husen B; Thole H; Rizner TL
Mol Cell Endocrinol; 2009 Mar; 301(1-2):59-64. PubMed ID: 18762229
[TBL] [Abstract][Full Text] [Related]
10. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma.
Utsunomiya H; Ito K; Suzuki T; Kitamura T; Kaneko C; Nakata T; Niikura H; Okamura K; Yaegashi N; Sasano H
Clin Cancer Res; 2004 Sep; 10(17):5850-6. PubMed ID: 15355916
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of 17β-hydroxysteroid dehydrogenase isozymes in human ovarian surface epithelium and epithelial ovarian carcinoma.
Motohara K; Tashiro H; Taura Y; Ohba T; Katabuchi H
Med Mol Morphol; 2010 Dec; 43(4):197-203. PubMed ID: 21267695
[TBL] [Abstract][Full Text] [Related]
12. Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis.
Hevir N; Vouk K; Sinkovec J; Ribič-Pucelj M; Rižner TL
Chem Biol Interact; 2011 May; 191(1-3):217-26. PubMed ID: 21232532
[TBL] [Abstract][Full Text] [Related]
13. Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues.
Miki Y; Nakata T; Suzuki T; Darnel AD; Moriya T; Kaneko C; Hidaka K; Shiotsu Y; Kusaka H; Sasano H
J Clin Endocrinol Metab; 2002 Dec; 87(12):5760-8. PubMed ID: 12466383
[TBL] [Abstract][Full Text] [Related]
14. Steroid sulfatase and estrogen sulfotransferase in the atherosclerotic human aorta.
Nakamura Y; Miki Y; Suzuki T; Nakata T; Darnel AD; Moriya T; Tazawa C; Saito H; Ishibashi T; Takahashi S; Yamada S; Sasano H
Am J Pathol; 2003 Oct; 163(4):1329-39. PubMed ID: 14507642
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of steroidogenic enzymes according to endometriosis type.
Colette S; Defrère S; Van Kerk O; Van Langendonckt A; Dolmans MM; Donnez J
Fertil Steril; 2013 Dec; 100(6):1642-9. PubMed ID: 24012197
[TBL] [Abstract][Full Text] [Related]
16. Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patients.
Suzuki M; Ishida H; Shiotsu Y; Nakata T; Akinaga S; Takashima S; Utsumi T; Saeki T; Harada N
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):195-201. PubMed ID: 19159687
[TBL] [Abstract][Full Text] [Related]
17. Induction of steroid sulfatase expression in PC-3 human prostate cancer cells by insulin-like growth factor II.
Sung CH; Im HJ; Park N; Kwon Y; Shin S; Ye DJ; Cho NH; Park YS; Choi HK; Kim D; Chun YJ
Toxicol Lett; 2013 Nov; 223(2):109-15. PubMed ID: 24055520
[TBL] [Abstract][Full Text] [Related]
18. High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer.
Cornel KM; Krakstad C; Delvoux B; Xanthoulea S; Jori B; Bongers MY; Konings GF; Kooreman LF; Kruitwagen RF; Salvesen HB; ; Romano A
Mol Cell Endocrinol; 2017 Feb; 442():51-57. PubMed ID: 27923582
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and progesterone metabolism in the cervix during pregnancy and parturition.
Andersson S; Minjarez D; Yost NP; Word RA
J Clin Endocrinol Metab; 2008 Jun; 93(6):2366-74. PubMed ID: 18364378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
